登录

Changmugu Completed Tens of Millions of Yuan Pre-A Round Financing

作者: Mailman 2019-09-25 12:09
长木谷
http://www.changmugu.com/
企业数据由 动脉橙 提供支持
骨科人工智能与手术机器人解决方案开发商 | B+轮 | 运营中
中国-北京
2022-03-24
华金资本
查看

According to 36Kr, Changmugu, an AI product developer in orthopedics, has received tens of millions of yuan in Pre-A round financing, led by Legend Star, followed by Frees Fund and Wanhui Capital. This round of financing will be mainly used to expand the AI orthopedic product line, promote the application of clinical registration certificate and accelerate the clinical implementation of AI products.


Founded in 2017, Changmugu focuses on orthopedic artificial intelligence, providing a series of artificial intelligence solutions for the whole process of orthopedic surgery, including preoperative evaluation, surgical planning, 3D printing, and customized surgical navigation guiding. In November 2019, Changmugu got tens of millions of yuan in seed round financing, led by Frees Fund.


Changmugu independently developed the fourth generation of its 3D surgical solution for joint replacement surgery, based on artificial intelligence deep learning. It integrates methods such as surgical simulation algorithm, image algorithm, deep learning algorithm in computer to realize 3D precise preoperative planning, including the visualization, standardization, and automation of orthopedic surgery. 


In addition, combined with the surgical navigation guide of 3D printing, the customized plan can be accurately implemented in the surgical process to improve the precision and safety of joint replacement surgery, with strong repeatability, and effectively reduce the incidence of postoperative complications.


>>>>

About Frees Fund


Frees Fund helps outstanding startups grow into great enterprises that will be valuable to our society. It mainly invests in early-stage and early growth-stage startups since 2015. Frees Fund focuses on two fields, Retail and Deep Tech, and several industries such as Education, Fintech, A.I., Biotech and Pharmaceuticals, New Energy, Industry 4.0 and more.


>>>>

About Legend Star


Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions, and an entrepreneurs alliance. Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated into the Chinese entrepreneurial ecosystem.


Legend Star is the independent early-stage investment arm of Legend Holdings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Imsight Technology Raises ¥10M in a New Round of Financing

Kunlun Invests ¥30M in CuraCloud To Expand its AI-Powered Business

AI技术公司Concerto HealthAI完成1.5亿美元B轮融资,开发精准肿瘤治疗方案

CMCDI Invests in iFlytek Healthcare for 60 Million Yuan

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Blue Sail Medical Acquired NVTAG for 178 Million Euros

2019-09-25
下一篇

构建大健康“政用产学研”闭环,天亿健康产业园落户前湾新区

2019-09-25